MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 6771-6780 Newer>
Pharmaceutical Executive
September 1, 2010
Tracking Meetings in Troubled Times Scrutiny of pharmaceutical promotion and gifts to practitioners has intensified, with more states enacting reporting requirements. What kind of impact is all this having on meetings and physician attendance? mark for My Articles 406 similar articles
Pharmaceutical Executive
September 1, 2010
William Looney
The Coming Second Act Reinvention takes more than a pithy redraft of the strategy plan or mission statement; money, a change in business culture, and the mindset of thousands of employees is required too. mark for My Articles 85 similar articles
Pharmaceutical Executive
September 1, 2010
The Testing of the Tests FDA seeks to regulate genetic tests more actively, while encouraging diagnostic development. mark for My Articles 534 similar articles
The Motley Fool
October 12, 2010
Seth Jayson
Where Is PerkinElmer's Bottom Line Headed? Here's the current margin snapshot for PerkinElmer and some of its sector and industry peers and direct competitors. mark for My Articles 952 similar articles
The Motley Fool
October 12, 2010
Brian Orelli
This Drugmaker Stands on a Platform Above the Rest ImmunoGen signs up another partner. mark for My Articles 112 similar articles
The Motley Fool
October 12, 2010
Travis Hoium
Geron Shares Popped: What You Need to Know Geron shares jumped 10% after the company announced that its first patient has enrolled in the company's stem cell clinical trial. mark for My Articles 187 similar articles
The Motley Fool
October 12, 2010
Travis Hoium
King Pharmaceuticals Shares Popped: What You Need to Know King Pharmaceuticals shares are up nearly 40% today after it was announced the company would be purchased by Pfizer Inc. mark for My Articles 306 similar articles
The Motley Fool
October 12, 2010
Brian Orelli
Clinical Trial Positive! Shares Just Barely A story about expectations. Seattle Genetics is two for two in recent weeks. mark for My Articles 186 similar articles
The Motley Fool
October 11, 2010
Brian Orelli
FDA Rejection, but Still Jazzed Up Sometimes, biotechs are like that. mark for My Articles 478 similar articles
The Motley Fool
October 11, 2010
Brian Orelli
A Dendreon Killer? Not Yet. Johnson & Johnson's abiraterone looks good, but won't knock off the newcomer. mark for My Articles 327 similar articles
<Older 6771-6780 Newer>    Return to current articles.